143 related articles for article (PubMed ID: 16103711)
41. High-throughput approaches to understanding gene function and mapping network architecture in bacteria.
Brochado AR; Typas A
Curr Opin Microbiol; 2013 Apr; 16(2):199-206. PubMed ID: 23403119
[TBL] [Abstract][Full Text] [Related]
42. Bioinformatics in microbial biotechnology--a mini review.
Bansal AK
Microb Cell Fact; 2005 Jun; 4():19. PubMed ID: 15985162
[TBL] [Abstract][Full Text] [Related]
43. Bacterial pathogen genomics and vaccines.
Moxon R; Rappuoli R
Br Med Bull; 2002; 62():45-58. PubMed ID: 12176849
[TBL] [Abstract][Full Text] [Related]
44. Immunomics: a 21st century approach to vaccine development for complex pathogens.
De Sousa KP; Doolan DL
Parasitology; 2016 Feb; 143(2):236-44. PubMed ID: 26864136
[TBL] [Abstract][Full Text] [Related]
45. Harnessing the power of omics in microbiology.
Teitzel G
Trends Microbiol; 2014 May; 22(5):227-8. PubMed ID: 24704145
[No Abstract] [Full Text] [Related]
46. Bioinformatics: use in bacterial vaccine discovery.
Zagursky RJ; Russell D
Biotechniques; 2001 Sep; 31(3):636, 638, 640, passim. PubMed ID: 11570507
[TBL] [Abstract][Full Text] [Related]
47. Genes to genetic immunization: identification of bacterial vaccine candidates.
Allan E; Wren BW
Methods; 2003 Nov; 31(3):193-8. PubMed ID: 14511951
[TBL] [Abstract][Full Text] [Related]
48. Genomics and proteomics in reverse vaccines.
Grandi G
Methods Biochem Anal; 2006; 49():379-93. PubMed ID: 16929688
[No Abstract] [Full Text] [Related]
49. Deciphering the human antigenome.
Sette A; Schenkelberg TR; Koff WC
Expert Rev Vaccines; 2016; 15(2):167-71. PubMed ID: 26629807
[TBL] [Abstract][Full Text] [Related]
50. Advanced strategies for development of vaccines against human bacterial pathogens.
Sharma A; Sanduja P; Anand A; Mahajan P; Guzman CA; Yadav P; Awasthi A; Hanski E; Dua M; Johri AK
World J Microbiol Biotechnol; 2021 Mar; 37(4):67. PubMed ID: 33748926
[TBL] [Abstract][Full Text] [Related]
51. Souvenirs.
Cohen GN
Res Microbiol; 2014 Jun; 165(5):325-6. PubMed ID: 24859146
[No Abstract] [Full Text] [Related]
52. Advances and applications of molecular cloning in clinical microbiology.
Sharma K; Mishra AK; Mehraj V; Duraisamy GS
Biotechnol Genet Eng Rev; 2014 Oct; 30(1-2):65-78. PubMed ID: 25023463
[TBL] [Abstract][Full Text] [Related]
53. François Jacob at the cutting edge.
Cuzin F
Res Microbiol; 2014 Jun; 165(5):365-6. PubMed ID: 24853965
[No Abstract] [Full Text] [Related]
54. François and "X".
Meselson M
Res Microbiol; 2014 Jun; 165(5):313-5. PubMed ID: 24853970
[No Abstract] [Full Text] [Related]
55. Recent advances and novel strategies in vaccine development.
Green BA; Baker SM
Curr Opin Microbiol; 2002 Oct; 5(5):483-8. PubMed ID: 12354555
[TBL] [Abstract][Full Text] [Related]
56. Memories of François Jacob: the inspirer and the friend.
Gros F
Res Microbiol; 2014 Jun; 165(5):331-2. PubMed ID: 24859139
[No Abstract] [Full Text] [Related]
57. Le "grand" François.
Ullmann A
Res Microbiol; 2014 Jun; 165(5):327-30. PubMed ID: 24859143
[No Abstract] [Full Text] [Related]
58. "A ce moment-là".
Davies J
Res Microbiol; 2014 Jun; 165(5):351-2. PubMed ID: 24873987
[No Abstract] [Full Text] [Related]
59. Molecular biology in orthopaedics: the advent of molecular orthopaedics.
Evans CH; Rosier RN
J Bone Joint Surg Am; 2005 Nov; 87(11):2550-64. PubMed ID: 16264134
[TBL] [Abstract][Full Text] [Related]
60. Transcriptomics and proteomics: tools for the identification of novel drug targets and vaccine candidates for tuberculosis.
Betts JC
IUBMB Life; 2002; 53(4-5):239-42. PubMed ID: 12121002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
